This activity already occurred and is no longer available.
Clinical Trials Network Mid-Winter Meeting Workshop 2011 - Clinical Trials Regulations and Implementation - Part I
Clinical Trials Network Mid-Winter Meeting Workshop 2011 - Clinical Trials Regulations and Implementation - Part I

Clinical Trials Network Mid-Winter Meeting Workshop 2011 - Clinical Trials Regulations and Implementation - Part I

Release date: 10-12-12
Expiration date: 10-12-15


Authors

John M. Hoffman, MD, is a consultant and investor in ContraDyn, Inc., and a consultant and researcher for GE Healthcare.

LisaAnn Trembath, CNMT, MSM, CCRA, NCT, FS, has nothing to disclose.

Marybeth Devine, CNMT, is employed by Lantheus Medical Imaging.

Gary J. Lunger, MSRIS, RT(R)(N)ARRT, is a board member of the Council of Radionuclides and Radiopharmaceuticals and is also employed by GlaxoSmithKline Pharmaceuticals.

Eileen O. Smith, MBA, CNMT, is employed by Molecular Neuroimaging, LLC.

Target Audience
Physicians, pharmacists, and technologists


Objectives
At the completion of this activity, the participant will be able to:

1. Discuss the essential regulations that govern performing clinical research on humans.
2. Describe the role of imaging personnel in regards to source documentation and reporting adverse events.
3. Discuss the key elements for achieving standardization in imaging trials and its impact on drug development.

Continuing Education Credit Information

AMA-PRA (Physician)
SNMMI is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 3.75 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation. Release date: 10-12-12 Expiration date: 10-12-15


ACPE (Pharmacists)
SNMMI is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. The universal program number for this enduring material is 0210-0000-12-388-H04-P. Total available credit for pharmacists is 3.75 hour or .0375 CEUs. Release Date: 10-12-12 Expiration Date: 10-12-15 To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation.


VOICE (Technologists)

The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this journal article for a maximum of 3.75 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A credit. In order to receive CE credit, you must first complete the activity content. When completed, take the post-test assessment. You must obtain a score of 80% to receive the CE credit. You will have no more than 3 attempts to successfully complete the post-test. Release Date: 10-12-12 Expiration Date: 10-12-15 California Scope: 3.75 Imaging(I)/Non-Imaging(NI) / Radiopharmacy(R) / Therapy(T).

Minimum system requirements

Supported Internet Browsers:
- Microsoft Internet Explorer (version 7 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)
- Apple Safari (version 4 or higher)

Plug-in: Adobe Acrobat Reader (http://get.adobe.com/reader/)

For questions please contact the
Education Department.
©2014 SNMMI. All rights reserved.


Type:     Internet Activity (Enduring Material)
53 Registered Users